The U.S. wants to phase out animal research. Are the alternatives ready? – New Study
Drug and chemical safety can be assessed with AI and organ chips, but some scientists say it’s too soon to forgo animal methods entirely
Summary
Artificial intelligence (AI) and organ chips are emerging as promising tools for assessing drug and chemical safety, potentially reducing reliance on animal testing. AI can analyze vast datasets to predict toxicity, while organ chips mimic human organ function, offering more relevant results than animal models. However, some scientists caution against completely abandoning animal testing, arguing that current AI and organ chip technologies are not yet sophisticated enough to fully capture the complexities of biological systems and potential adverse effects. A balanced approach, combining these advanced methods with traditional animal studies where necessary, is crucial for ensuring accurate and comprehensive safety assessments.
Read more…
Credits: Source
This post is part of “Science/Immunology News”, Follow for more…!!!